Q&A – Guided Discussion on Estimating Onset of Alzheimer’s Symptoms with an Amyloid Clock

Description: A panel discussion, featuring researchers and a DIAN family member, on recent developments in early screening and detection of Alzheimer’s disease
Runtime: 00:37:11

Speaker: Eric McDade, DO
Speaker title: DIAN Trials Unit Co-Director
Speaker organization: Washington University in St. Louis

Speaker: Suzanne Schindler, MD, PhD
Speaker title: Fluid Biomarker Core Leader
Speaker organization: Washington University in St. Louis

Speaker: Teresa Buracchio, MD
Speaker title: Director, Office of Neuroscience
Speaker organization: US Food and Drug Administration

Speaker: Erik Johnson, MD, PhD
Speaker title: Assistant Professor, Neurology
Speaker organization: Emory University

Speaker: Kristin Wildsmith, PhD
Speaker title: Senior Director, Clinical Pharmacology and Translational Medicine
Speaker organization: Eisai

Speaker: Tasha Johnson

Event: 2024 Regional DIAD Family Conference: Moving Forward with Hope
Location: Philadelphia, Pennsylvania, USA
Year: 2024

Search tags: amyloid plaques, tau tangles, biomarkers, blood, plasma, CSF, cerebrospinal fluid, regulation, proteomics, preclinical Alzheimer’s, cognitive testing, clinical trials, Alzheimer’s screening, blood testing, blood screening, disease progression, drug targets, inflammation, lecanemab, donanemab, drug approval